Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-089023

Options or other derivatives

  • Chief Executive Officer acquired 460,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-27 Grant or award : show line 1 in the form Stock Option (right to buy) +460,000 460,000 D
Loading xslF345X05/ownership.xml…